Related Experiment Video
Updated: Feb 13, 2026
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
No Vacillation on HPV Vaccination
Douglas Sipp1, Ian H Frazer2, John E J Rasko3
1RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, Japan; Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan; Keio Global Research Institute, 2 Chome-15-45 Mita, Minato-ku, Tokyo, Japan; RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Building, 15th floor, 1-4-1 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan.
Human papillomavirus (HPV) vaccines are safe and prevent cancer, but low global uptake hinders population immunity. Policy changes are needed to increase worldwide HPV vaccination coverage and save lives.
Area of Science:
- Oncology
- Vaccinology
- Public Health
Background:
- The safety and anti-cancer benefits of human papillomavirus (HPV) vaccines are well-established.
- Despite overwhelming evidence, global HPV vaccine uptake remains insufficient to achieve herd immunity.
Purpose of the Study:
- To review policy measures that can enhance global HPV vaccine coverage.
- To identify strategies for increasing HPV vaccination rates worldwide to maximize cancer prevention.
Main Methods:
- This study synthesizes existing evidence on HPV vaccine efficacy and safety.
- It analyzes factors contributing to disparities in global vaccine uptake.
- Policy recommendations are derived from a review of successful public health interventions.
Main Results:
- Significant variations in HPV vaccine coverage exist across different countries.
- Current uptake levels are below the threshold required for effective population-level cancer prevention.
- Specific policy interventions can demonstrably improve vaccination rates.
Conclusions:
- Implementing targeted policy measures is crucial for improving global HPV vaccine coverage.
- Increased vaccination rates will lead to substantial reductions in HPV-related cancers.
- Global collaboration is essential to ensure equitable access and uptake of HPV vaccines.
Related Concept Videos
01:51Vaccinations
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...